NCT01173497: A Study Evaluating INIPARIB in Combination With Chemotherapy to Treat Triple Negative Breast Cancer Brain Metastasis |
|
|
| Completed | 2 | 44 | US | INIPARIB + irinotecan | Sanofi, UNC Lineberger Comprehensive Cancer Center | Estrogen Receptor Negative (ER-Negative) Breast Cancer, Progesterone Receptor Negative (PR-Negative) Breast Cancer, Human Epidermal Growth Factor Receptor 2 Negative (HER2-Negative) Breast Cancer, Brain Metastases | 10/12 | 07/13 | | |